학술논문

HLA-mismatched donor lymphocyte infusion is safe for the treatment of leukaemia relapse following alemtuzumab-based myeloablative allogeneic stem cell transplantation
Document Type
Journal
Source
BONE MARROW TRANSPLANTATION; APR 2013, 48 pS86-pS87, 2p. Supplement: 2
Subject
Language
English
ISSN
02683369